Literature DB >> 19174772

A case of tuberous sclerosis complex that progressed to end-stage renal disease.

Mohammad Sarraf1, Amirali Masoumi, Fernando J Castro-Silva, Jeremy B Myers, Shandra S Wilson, Robert W Schrier.   

Abstract

BACKGROUND: A 31-year-old woman with tuberous sclerosis complex presented with a 1 week history of subjective fever, chills, rigors, poor appetite and dizziness. INVESTIGATIONS: Physical examination, urine and blood analysis, CT of the abdomen, chest and brain, and chest X-ray. DIAGNOSIS: End-stage renal disease, septic shock and urinary tract infection secondary to huge bilateral angiomyolipomas of the kidney associated with tuberous sclerosis complex. MANAGEMENT: Antibiotic therapy, vasopressor treatment and bilateral nephrectomy, followed by hemodialysis while awaiting renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174772     DOI: 10.1038/ncpneph1033

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  11 in total

Review 1.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

2.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.

Authors:  M van Slegtenhorst; M Nellist; B Nagelkerken; J Cheadle; R Snell; A van den Ouweland; A Reuser; J Sampson; D Halley; P van der Sluijs
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

3.  Tuberous sclerosis and chronic renal failure. Potential confusion with polycystic kidney disease.

Authors:  D Anderson; R L Tannen
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

4.  Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex.

Authors:  David H Ewalt; Norman Diamond; Chet Rees; Steven P Sparagana; Mauricio Delgado; Lori Batchelor; E Steve Roach
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

5.  Inheritance of tuberous sclerosis.

Authors:  V P Sybert; J G Hall
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

Review 6.  Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association.

Authors:  E S Roach; F J DiMario; R S Kandt; H Northrup
Journal:  J Child Neurol       Date:  1999-06       Impact factor: 1.987

7.  Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.

Authors:  Han C Dan; Mei Sun; Lin Yang; Richard I Feldman; Xue-Mei Sui; Chien Chen Ou; Mark Nellist; Raymond S Yeung; Dicky J J Halley; Santo V Nicosia; Warren J Pledger; Jin Q Cheng
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

Review 8.  Tuberous sclerosis complex: genetics to pathogenesis.

Authors:  Vinodh Narayanan
Journal:  Pediatr Neurol       Date:  2003-11       Impact factor: 3.372

9.  Renal lesion growth in children with tuberous sclerosis complex.

Authors:  D H Ewalt; E Sheffield; S P Sparagana; M R Delgado; E S Roach
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

10.  Causes of death in patients with tuberous sclerosis.

Authors:  C W Shepherd; M R Gomez; J T Lie; C S Crowson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

View more
  4 in total

1.  Tuberous sclerosis-associated renal angiomyolipoma: A report of two cases and review of the literature.

Authors:  Canbin Lin; Lu Jin; Yu Yang; Yu Ding; Xionghui Wu; Liangchao Ni; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-08-14

Review 2.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

3.  A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal Angiomyolipomas.

Authors:  Wenda Wang; Gang Guo; Guohai Shi; Xin Wei; Zhiquan Hu; Hanzhong Li; Xu Zhang; Dingwei Ye; Yushi Zhang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.

Authors:  J Chris Kingswood; Sergiusz Jozwiak; Elena D Belousova; Michael D Frost; Rachel A Kuperman; E Martina Bebin; Bruce R Korf; J Robert Flamini; Michael H Kohrman; Steven P Sparagana; Joyce Y Wu; Thomas Brechenmacher; Karen Stein; Noah Berkowitz; John J Bissler; David N Franz
Journal:  Nephrol Dial Transplant       Date:  2014-04-11       Impact factor: 5.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.